Orion looks to tap Japan's bioventure potential
This article was originally published in Scrip
Executive Summary
Dr Jones is one of only a handful of non-Japanese in the local pharmaceutical industry who can lay claim to having some long-term perspective on the industry, having lived in the country for around 15 years. "I now find that I've been in the industry longer than some of the Japanese executives I meet," he quipped in an interview at his Tokyo home.